Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Vista Gen Therapeutics, Inc. announced it raised $1.93 Million in an initial filing from an offering of $10 Million

PUBLIC · VTGNAug 06, 2015•about 11 years ago

Amount Raised

$1.93 Million

Round Type

Venture - Series Unknown

South San FranciscoBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Company Information

Company

VistaGen

Location

343 Allerton Avenue

South San Francisco, California, United States

About

Vistagen is a late clinical-stage biopharmaceutical company headquartered in South San Francisco, CA, developing and commercializing a new class of intranasal product candidates called pherines. Leveraging advanced insights into nose-to-brain neurocircuitry, Vistagen designs pherines to selectively activate peripheral nasal chemosensory receptors and rapidly trigger olfactory bulb–to-brain pathways that influence behavior and autonomic nervous system activity. Because they are engineered to work without entering the bloodstream or brain, pherines have the potential to offer safer therapeutic alternatives to existing pharmacological treatments if successfully developed and approved.

Don't miss VistaGen's next move

Get an email the moment VistaGen raises, hires an exec, or expands — usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
1 contact
Verified contacts24 people are listed at VistaGen — we don't have their email yet.
Predictive Intelligence
Strategic

ML-powered predictions for VistaGen's next move

Learn about Strategic plan

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.